Global Antidepressants Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	138 Pages	TechNavio	July, 2024	INF19115263

Best Price Guarantee
Price	from $2,500
Length	138 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19115263

Global Antidepressants Drugs Market 2024-2028

Global Antidepressants Drugs Market 2024-2028

The antidepressants drugs market is forecasted to grow by USD 4.25 bn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the antidepressants drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of depression, alliances and collaborations, and awareness programs for depression.

Technavio's antidepressants drugs market is segmented as below:

By Disease Type
Major depressive disorder
Obsessive compulsive disorder
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the development and approval of new drugs as one of the prime reasons driving the antidepressants drugs market growth during the next few years. Also, increasing R and D investments by vendors and advent of regenerative medicines will lead to sizable demand in the market.

The report on the antidepressants drugs market covers the following areas:

Antidepressants drugs market sizing
Antidepressants drugs market forecast
Antidepressants drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antidepressants drugs market vendors that include AbbVie Inc., Alkermes Public Ltd. Co., Bausch Health Companies Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., H Lundbeck AS, Johnson and Johnson Services Inc., Lupin Ltd., Luye Pharma Group Ltd., MagVenture AS, Otsuka Holdings Co. Ltd., Pfizer Inc., SK Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the antidepressants drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Disease Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ billion); Data Table on Global - Market size and forecast 2023-2028 ($ billion); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Antidepressants Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global Antidepressants Drugs Market 2018 - 2022 ($ billion); 4.2 Disease Type segment analysis 2018 - 2022; Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion); 4.3 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.4 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Disease Type: 6.1 Market segments; Chart on Disease Type - Market share 2023-2028 (%); Data Table on Disease Type - Market share 2023-2028 (%); 6.2 Comparison by Disease Type; Chart on Comparison by Disease Type; Data Table on Comparison by Disease Type; 6.3 Major depressive disorder - Market size and forecast 2023-2028; Chart on Major depressive disorder - Market size and forecast 2023-2028 ($ billion); Data Table on Major depressive disorder - Market size and forecast 2023-2028 ($ billion); Chart on Major depressive disorder - Year-over-year growth 2023-2028 (%); Data Table on Major depressive disorder - Year-over-year growth 2023-2028 (%); 6.4 Obsessive compulsive disorder - Market size and forecast 2023-2028; Chart on Obsessive compulsive disorder - Market size and forecast 2023-2028 ($ billion); Data Table on Obsessive compulsive disorder - Market size and forecast 2023-2028 ($ billion); Chart on Obsessive compulsive disorder - Year-over-year growth 2023-2028 (%); Data Table on Obsessive compulsive disorder - Year-over-year growth 2023-2028 (%); 6.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ billion); Data Table on Others - Market size and forecast 2023-2028 ($ billion); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Disease Type; Market opportunity by Disease Type ($ billion); Data Table on Market opportunity by Disease Type ($ billion)
7 Customer Landscape: 7.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape: 8.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 8.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 8.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ billion); Data Table on North America - Market size and forecast 2023-2028 ($ billion); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 8.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ billion); Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 8.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ billion); Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 8.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 8.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ billion); Data Table on US - Market size and forecast 2023-2028 ($ billion); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 8.8 Greece - Market size and forecast 2023-2028; Chart on Greece - Market size and forecast 2023-2028 ($ billion); Data Table on Greece - Market size and forecast 2023-2028 ($ billion); Chart on Greece - Year-over-year growth 2023-2028 (%); Data Table on Greece - Year-over-year growth 2023-2028 (%); 8.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ billion); Data Table on China - Market size and forecast 2023-2028 ($ billion); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 8.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ billion); Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 8.11 India - Market size and forecast 2023-2028; Chart on India - Market size and forecast 2023-2028 ($ billion); Data Table on India - Market size and forecast 2023-2028 ($ billion); Chart on India - Year-over-year growth 2023-2028 (%); Data Table on India - Year-over-year growth 2023-2028 (%); 8.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
9 Drivers, Challenges, and Opportunity/Restraints: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 9.4 Market opportunities/restraints
10 Competitive Landscape: 10.1 Overview; 10.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 10.3 Landscape disruption; Overview on factors of disruption; 10.4 Industry risks; Impact of key risks on business
11 Competitive Analysis: 11.1 Companies profiled; Companies covered; 11.2 Market positioning of companies; Matrix on companies position and classification; 11.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 11.4 Alkermes Public Ltd. Co.; Alkermes Public Ltd. Co. - Overview; Alkermes Public Ltd. Co. - Product / Service; Alkermes Public Ltd. Co. - Key offerings; 11.5 Bausch Health Companies Inc.; Bausch Health Companies Inc. - Overview; Bausch Health Companies Inc. - Business segments; Bausch Health Companies Inc. - Key news; Bausch Health Companies Inc. - Key offerings; Bausch Health Companies Inc. - Segment focus; 11.6 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key news; Eli Lilly and Co. - Key offerings; 11.7 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 11.8 H Lundbeck AS; H Lundbeck AS - Overview; H Lundbeck AS - Product / Service; H Lundbeck AS - Key offerings; 11.9 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 11.10 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Product / Service; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; 11.11 MagVenture AS; MagVenture AS - Overview; MagVenture AS - Product / Service; MagVenture AS - Key offerings; 11.12 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 12.3 Currency conversion rates for US$; Currency conversion rates for US$; 12.4 Research methodology; Research methodology; 12.5 Data procurement; Information sources; 12.6 Data validation; Data validation; 12.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 12.8 Data synthesis; Data synthesis; 12.9 360 degree market analysis; 360 degree market analysis; 12.10 List of abbreviations; List of abbreviations; Exhibits:; Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type; Exhibits6: Executive Summary - Chart on Incremental Growth; Exhibits7: Executive Summary - Data Table on Incremental Growth; Exhibits8: Executive Summary - Chart on Company Market Positioning; Exhibits9: Parent Market; Exhibits10: Data Table on - Parent Market; Exhibits11: Market characteristics analysis; Exhibits12: Value Chain Analysis; Exhibits13: Offerings of companies included in the market definition; Exhibits14: Market segments; Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Historic Market Size - Data Table on Global Antidepressants Drugs Market 2018 - 2022 ($ billion); Exhibits20: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Disease Type - Market share 2023-2028 (%); Exhibits31: Data Table on Disease Type - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Disease Type; Exhibits33: Data Table on Comparison by Disease Type; Exhibits34: Chart on Major depressive disorder - Market size and forecast 2023-2028 ($ billion); Exhibits35: Data Table on Major depressive disorder - Market size and forecast 2023-2028 ($ billion); Exhibits36: Chart on Major depressive disorder - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Major depressive disorder - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Obsessive compulsive disorder - Market size and forecast 2023-2028 ($ billion); Exhibits39: Data Table on Obsessive compulsive disorder - Market size and forecast 2023-2028 ($ billion); Exhibits40: Chart on Obsessive compulsive disorder - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Obsessive compulsive disorder - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Disease Type ($ billion); Exhibits47: Data Table on Market opportunity by Disease Type ($ billion); Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits51: Chart on Geographic comparison; Exhibits52: Data Table on Geographic comparison; Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Greece - Market size and forecast 2023-2028 ($ billion); Exhibits74: Data Table on Greece - Market size and forecast 2023-2028 ($ billion); Exhibits75: Chart on Greece - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Greece - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits78: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits79: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on India - Market size and forecast 2023-2028 ($ billion); Exhibits86: Data Table on India - Market size and forecast 2023-2028 ($ billion); Exhibits87: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits89: Market opportunity By Geographical Landscape ($ billion); Exhibits90: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits91: Impact of drivers and challenges in 2023 and 2028; Exhibits92: Overview on criticality of inputs and factors of differentiation; Exhibits93: Overview on factors of disruption; Exhibits94: Impact of key risks on business; Exhibits95: Companies covered; Exhibits96: Matrix on companies position and classification; Exhibits97: AbbVie Inc. - Overview; Exhibits98: AbbVie Inc. - Product / Service; Exhibits99: AbbVie Inc. - Key news; Exhibits100: AbbVie Inc. - Key offerings; Exhibits101: Alkermes Public Ltd. Co. - Overview; Exhibits102: Alkermes Public Ltd. Co. - Product / Service; Exhibits103: Alkermes Public Ltd. Co. - Key offerings; Exhibits104: Bausch Health Companies Inc. - Overview; Exhibits105: Bausch Health Companies Inc. - Business segments; Exhibits106: Bausch Health Companies Inc. - Key news; Exhibits107: Bausch Health Companies Inc. - Key offerings; Exhibits108: Bausch Health Companies Inc. - Segment focus; Exhibits109: Eli Lilly and Co. - Overview; Exhibits110: Eli Lilly and Co. - Product / Service; Exhibits111: Eli Lilly and Co. - Key news; Exhibits112: Eli Lilly and Co. - Key offerings; Exhibits113: F. Hoffmann La Roche Ltd. - Overview; Exhibits114: F. Hoffmann La Roche Ltd. - Business segments; Exhibits115: F. Hoffmann La Roche Ltd. - Key news; Exhibits116: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits117: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits118: H Lundbeck AS - Overview; Exhibits119: H Lundbeck AS - Product / Service; Exhibits120: H Lundbeck AS - Key offerings; Exhibits121: Johnson and Johnson Services Inc. - Overview; Exhibits122: Johnson and Johnson Services Inc. - Business segments; Exhibits123: Johnson and Johnson Services Inc. - Key news; Exhibits124: Johnson and Johnson Services Inc. - Key offerings; Exhibits125: Johnson and Johnson Services Inc. - Segment focus; Exhibits126: Lupin Ltd. - Overview; Exhibits127: Lupin Ltd. - Product / Service; Exhibits128: Lupin Ltd. - Key news; Exhibits129: Lupin Ltd. - Key offerings; Exhibits130: MagVenture AS - Overview; Exhibits131: MagVenture AS - Product / Service; Exhibits132: MagVenture AS - Key offerings; Exhibits133: Viatris Inc. - Overview; Exhibits134: Viatris Inc. - Business segments; Exhibits135: Viatris Inc. - Key news; Exhibits136: Viatris Inc. - Key offerings; Exhibits137: Viatris Inc. - Segment focus; Exhibits138: Inclusions checklist; Exhibits139: Exclusions checklist; Exhibits140: Currency conversion rates for US$; Exhibits141: Research methodology; Exhibits142: Information sources; Exhibits143: Data validation; Exhibits144: Validation techniques employed for market sizing; Exhibits145: Data synthesis; Exhibits146: 360 degree market analysis; Exhibits147: List of abbreviations